EUVIMEDEUVIMED entdecken
Open Access

Galangin mitigates glucocorticoid-induced osteoporosis by activating autophagy of BMSCs via triggering the PKA/CREB signaling pathway

Chenying Zeng, Shan Wang, Huimin Gu, Fenglei Chen, Ziming Wang, Jinteng Li, Zhongyu Xie, Pei Feng, Huiyong Shen, Yanfeng Wu

Acta Biochimica et Biophysica Sinica · 2023

DOI: 10.3724/abbs.2023063 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biochimica et Biophysica Sinica, 2023. Verfasst von Chenying Zeng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Biotherapy, Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen 518033, China. Hauptthemen laut MEDLINE: Glucocorticoids, Osteoporosis. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glucocorticoid-induced osteoporosis (GIOP), one of the most common and serious adverse effects associated with glucocorticoid administration, manifests as decreased bone formation and increased bone resorption, eventually culminating in bone loss. Galangin (GAL) is a flavonoid extracted from the medicinal herbal galangal that possesses a variety of pharmacological activities and can inhibit osteoclastogenesis. However, the effects of GAL on GIOP remain unclear. Our study aims to explore the effects of GAL on GIOP in mice and the underlying mechanism. Our results show that GAL markedly mitigates the severity of dexamethasone (Dex)-induced osteoporosis in mice and potentiates osteogenic differentiation in mouse bone marrow-derived mesenchymal stem cells (BMSCs). Furthermore, GAL also significantly counteracts Dex-mediated suppression of osteogenic differentiation and autophagy in human BMSCs. GAL augments PKA/CREB-mediated autophagic flux in BMSCs and the bones of osteoporotic mice. GAL-mediated osteogenic differentiation in Dex-treated BMSCs is significantly decreased by the PKA inhibitor H89 and autophagy inhibitor 3-methyladenine. Collectively, our data indicate that GAL can ameliorate GIOP, partly by augmenting the mineralization of BMSCs by potentiating PKA/CREB-mediated autophagic flux, highlighting its potential therapeutic use in treating glucocorticoid-related osteoporosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlucocorticoidsOsteoporosisHumansMiceAnimalsOsteogenesisFlavonoidsSignal TransductionCell DifferentiationAutophagy

Stichwörter der Autor:innen

BMSCautophagydexamethasonegalanginglucocorticoid-induced osteoporosis

Substanzen

GlucocorticoidsgalanginFlavonoids

Autor:innen und Institutionen

  • Center for Biotherapy, Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen 518033, China.
  • Department of Orthopedics, Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen 518033, China.
  • Department of Orthopedics, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou 510120, China.

Zitieren

APA

Zeng, C., Wang, S., Gu, H., Chen, F., Wang, Z., Li, J., Xie, Z., Feng, P., Shen, H., & Wu, Y. (2023). Galangin mitigates glucocorticoid-induced osteoporosis by activating autophagy of BMSCs via triggering the PKA/CREB signaling pathway. Acta Biochimica et Biophysica Sinica. https://doi.org/10.3724/abbs.2023063

Vancouver

Zeng C, Wang S, Gu H, Chen F, Wang Z, Li J, et al. Galangin mitigates glucocorticoid-induced osteoporosis by activating autophagy of BMSCs via triggering the PKA/CREB signaling pathway. Acta Biochimica et Biophysica Sinica. 2023. doi:10.3724/abbs.2023063

BibTeX
@article{Zeng2023,
  author = {Zeng, Chenying and Wang, Shan and Gu, Huimin and Chen, Fenglei and Wang, Ziming and Li, Jinteng and Xie, Zhongyu and Feng, Pei and Shen, Huiyong and Wu, Yanfeng},
  title = {Galangin mitigates glucocorticoid-induced osteoporosis by activating autophagy of BMSCs via triggering the PKA/CREB signaling pathway},
  journal = {Acta Biochimica et Biophysica Sinica},
  year = {2023},
  doi = {10.3724/abbs.2023063}
}
Kostenlos starten →